Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:38 PM
Ignite Modification Date:
2025-12-24 @ 10:38 PM
NCT ID:
NCT01236235
Eligibility Criteria:
Inclusion Criteria:
* Male or Female HIV patients ≥ 18 years old at ATV/RTV initiation treatment date
* Outpatient seen in routine consultation whatever the reason, between January 1st 2011 and March 31st 2012
* Commencing an ATV/RTV-based regimen including at least 2 nucleoside reverse transcriptase inhibitors (NRTI) after February 1st 2008 and before July 31st 2010, regardless of the current ARV treatment ongoing at enrollment visit
Exclusion Criteria:
* Patient exposed to or who began ATV/RTV prior to February 1st 2008, or after July 31st 2010 or without a known start date for ATV/RTV therapy
* Exposure to more than 4 weeks of any ARV prior to initiation of ATV/RTV treatment
* Participation in a clinical trial with ATV at the time of or after initiation of ATV/RTV-based regimen
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01236235
Study Brief:
Protocol Section:
NCT01236235